Clinical Trials Directory

Trials / Completed

CompletedNCT03059836

n3 PUFA and Muscle-disuse Atrophy in Young Women

Effects of n3 PUFA Supplementation on the Attenuation of Muscle Disuse Atrophy in Young Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
McMaster University · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

This study will examine the influence of n3 PUFA supplementation on the rate of muscle atrophy in women undergoing 2 weeks of unilateral limb immobilization. Assessments in skeletal muscle strength and skeletal muscle volume will also me made before, after and in recovery from immobilization.

Detailed description

Biological aging is associated with the loss of skeletal muscle mass and strength resulting in compromised metabolic function and mobility. Throughout life, individuals will also experience periods of reduced physical activity/muscle disuse that independently lower muscle mass and strength accelerating the aging process. The losses in muscle mass with aging and disuse are underpinned by feeding-induced declines in rates of muscle protein synthesis. Thus, strategies to enhance muscle protein synthesis could have clinical implications for those who wish to maintain metabolic health and function during times of muscle disuse. Supplementation with n3 PUFA-enriched fish oil has been shown to potentiate rates of muscle protein synthesis in response to simulated feeding in both younger and older adults. Fish oil supplementation also has been efficacious in enhancing skeletal muscle strength during a period of resistance exercise training. However, no study has examined the impact of fish oil supplementation to enhance muscle protein synthesis and offset declines in muscle mass/strength during a period of immobilization.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTn3 PUFA-enriched fish oil3000mg of Eicosapentaenoic acid per day and 1800mg of Docosahexaenoic acid per day
DIETARY_SUPPLEMENTPlaceboOrganic Sunflower Oil 5000mg per day

Timeline

Start date
2017-02-28
Primary completion
2018-02-28
Completion
2018-02-28
First posted
2017-02-23
Last updated
2018-03-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03059836. Inclusion in this directory is not an endorsement.